Trifecta Capital Advisors, LLC Novo Nordisk A S Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 610 shares of NVO stock, worth $65,215. This represents 0.02% of its overall portfolio holdings.
Number of Shares
610
Previous 610
-0.0%
Holding current value
$65,215
Previous $87.1 Million
16.58%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,953Shares Held
320MCall Options Held
5.39MPut Options Held
5.46M-
Jennison Associates LLC20.2MShares$2.16 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.56 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.52 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.42 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.34 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $241B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...